(Q24625246)

English

Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression (English)
0 references
Ling Wang
0 references
Ngoc L Toomey
0 references
Luis A Diaz
0 references
Gail Walker
0 references
Juan C Ramos
0 references
Glen N Barber
0 references
Shunbin Ning
0 references
August 2011
0 references
85
0 references
16
0 references
8328-37
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit